Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / V••••••• T••••••••• I•••

V••••••• T••••••••• I•••

Stage unknownNew York, NYPharmaceuticals
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Sep 8, 2025
    Form D equity offering · $30.1M (form d sold) · 11 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “V••••••• T••••••••• I••• filed Form D: $30,099,998 sold of $30,099,998, Pharmaceuticals”
  2. May 17, 2024
    Form D equity offering · $15.0M (form d sold) · 2 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “V••••••• T••••••••• I••• filed Form D: $15,000,000 sold of $15,000,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
4 officers, 15 directors
Timeline
2
  1. Sep 23, 2025
    V••••••• T••••••••• I••• filed Form D: $30,099,998 sold of $30,099,998, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. May 30, 2024
    V••••••• T••••••••• I••• filed Form D: $15,000,000 sold of $15,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company